Britt-Marie Frost
Affilierad Forskare vid Institutionen för kvinnors och barns hälsa; Barnonkologisk och neurologisk forskning
- Telefon:
- 018-611 58 02, 018-611 58 83
- Mobiltelefon:
- 070-516 98 93
- E-post:
- britt-marie.frost@uu.se
- Besöksadress:
- MTC-huset, Dag Hammarskjölds väg 14B, 1 tr
752 37 Uppsala - Postadress:
- Akademiska sjukhuset
751 85 UPPSALA
- Akademiska meriter:
- Docent, överläkare
Mer information visas för dig som medarbetare om du loggar in.
Publikationer
Senaste publikationer
- Is there a choice when a sibling is ill? (2022)
- DNA methylation holds prognostic information in relapsed precursor B-cell acute lymphoblastic leukemia (2018)
- Successful treatment with placenta-derived decidual stromal cells in a pediatric patient with life-threatening acute gastrointestinal graft-versus-host disease (2017)
- Aryl Hydrocarbon Receptor-Interacting Protein-Like 1 in Cancer-Associated Retinopathy (2016)
- Children with cancer share their views (2016)
Alla publikationer
Artiklar
- Is there a choice when a sibling is ill? (2022)
- DNA methylation holds prognostic information in relapsed precursor B-cell acute lymphoblastic leukemia (2018)
- Successful treatment with placenta-derived decidual stromal cells in a pediatric patient with life-threatening acute gastrointestinal graft-versus-host disease (2017)
- Aryl Hydrocarbon Receptor-Interacting Protein-Like 1 in Cancer-Associated Retinopathy (2016)
- Children with cancer share their views (2016)
- The Mutational Landscape in Pediatric Acute Lymphoblastic Leukemia Deciphered by Whole Genome Sequencing (2015)
- Prognostic implications of mutations in NOTCH1 and FBXW7 in childhood T-ALL treated according to the NOPHO ALL-1992 and ALL-2000 protocols. (2014)
- Flow Cytometric Leukemic Blasts Detection in Cerebrospinal Fluid of Children with Acute Lymphoblastic Leukemia (2014)
- Transition to noncurative end-of-life care in paediatric oncology (2013)
- Genome-wide signatures of differential DNA methylation in pediatric acute lymphoblastic leukemia (2013)
- Genome-wide analysis of cytogenetic aberrations in ETV6/RUNX1-positive childhood acute lymphoblastic leukaemia. (2012)
- Individualized toxicity-titrated 6-mercaptopurine increments during high-dose methotrexate consolidation treatment of lower risk childhood acute lymphoblastic leukaemia. A Nordic Society of Paediatric Haematology and Oncology (NOPHO) pilot study (2011)
- In vitro cellular drug resistance adds prognostic information to other known risk-factors in childhood acute lymphoblastic leukemia (2011)
- Etoposide pharmacokinetics in children treated for acute myeloid leukemia (2006)
- Translocation t(1;19) is related to low cellular drug resistance in childhood acute lymphoblastic leukaemia (2005)
- Cellular drug sensitivity in MLL-rearranged childhood acute leukaemia is correlated to partner genes and cell lineage. (2005)
- Translocation t(12;21) is related to in vitro cellular drug sensitivity to doxorubicin and etoposide in childhood acute lymphoblastic leukemia. (2004)
- Pharmacokinetics of Doxorubicin in Children with Acute Lymphoblastic Leukemia (2002)
- In vitro activity of the novel cytotoxic agent CHS 828 in childhood acute leukemia (2002)
- Identification of somatic single nucleotide variants inleukemia by targeted sequencing of non-indexed overlapping pools